$Mazda Motor(7261.JP)$
I like MAZDA cars, so I want stocks too. But I'm scared

Research results on Eisai's dementia drug lecanemab being highly effective with continuous use
July 31, 2024 9:22 AM GMT+9
Research results showing that the effects of the Alzheimer's disease treatment drug “lecanemab,” which were jointly developed by Eisai and US Biogen, increased with continuous use on early-stage patients, and that there were no new safety issues were presented at the Alzheimer's Association's international conference held in Philadelphia, USA on the 30th.
When effects were investigated on approximately 95% of clinical investigators who continued treatment, the decline in cognitive function was suppressed by 31% compared to patients who did not receive treatment after 3 years.
Also, no new safety issues have been identified during the past 3 years. According to Christopher Van Dyke of the Yale University Alzheimer's Disease Research Team, symptoms such as brain swelling and bleeding associated with lecanemab mainly occurred within 6 months of starting treatment. Recanemab has the function of removing amyloid from the brain.
Lin Kramer, Eisai's chief clinical officer, stated in an interview with Reuters that “it is definitely more effective in the long term than in the short term.”

$Advanced Micro Devices(AMD.US)$
It's a slight increase
It's not going back to the purchase price

$Ecopetrol(EC.US)$ I will continue to buy 10 shares a month.

Beginners should not try their hand at it easilyN Bull 2x ETF (NVDU) 😅
Moomoo also has a lot of beginners, so risks etc. should be properly presented in an easy-to-understand mannerThere are people who get burnt without understanding
In particular, in a place called community, I think the management side should also present risks and share them with investors (users)
Characteristics and risks of leveraged ETFs and inverse ETFs
Leveraged ETFs and inverse ETFs are riskier than other ETFs that don't use leverage because they pursue leveraged investment goals every day. You can't expect to pursue daily goals and track the underlying index over a period of more than a day. It is not suitable for all investors and should only be used by skilled investors who understand leverage risk and actively manage their investments.
Investing in funds involves a high level of risk. Unlike conventional ETFs and other leveraged ETFs and inverse ETFs, these leveraged ETFs and inverse ETFs...

$Direxion Daily NVDA Bull 2X Shares(NVDU.US)$
$GraniteShares 2x Long NVDA Daily ETF(NVDL.US)$
I'm thinking of buying an NVDU or NVDL, but I'm not sure which one to use.
I don't think there's a big difference, but what was your deciding factor in choosing?

US AT&T, mobile phone subscribers exceeded expectations and expensive unlimited plans are doing well
July 25, 2024 at 3:44 AM GMT+9
The number of mobile phone subscribers exceeded market expectations in the 2nd quarter (fiscal year ending April to June) financial results announced by AT&T, a major US telecommunications company on the 24th. The background is that contracts for expensive unlimited plans have increased.
The number of mobile phone subscribers in the second quarter increased by 419,000 after deduction, and the increase exceeded the 284,800 predicted by analysts compiled by FactSet.
Free cash flow was 4.6 billion dollars, up 9% from the same period last year. The LSEG forecast was 4,220 million dollars.

$USD/JPY(USDJPY.FX)$
I have no idea what the Japanese government of the Liberal Democratic Party wants to do.
Shortly after the start of the new NISA system, it led to an appreciation of the yen.
Kanda, let's answer. Is the new NISA a trap?

$Skylark Holdings(3197.JP)$ It was sold short but it came back, and this move is too suspicious! Are you going to buy it back or cash it out? Do they even sell analyst (liar) ratings (selling prices)? What do you think?